BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-848@pharmaconomics
DTSTAMP:20260707T015648Z
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260429
SUMMARY:PTCT Phase 3 — votoplam
DESCRIPTION:Phase 3 trial results for votoplam in Huntington's disease are due Apr 28\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1070081/000107008126000006/tmb-20260428xex99d1.htm\n\nTrack it: https://pharmaconomics.com/e/848
URL:https://pharmaconomics.com/e/848
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PTCT catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR